Trial Profile
Bedaquiline Patient Registry: Prospective Patient Registry of Patients Exposed to Bedaquiline In the United States
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary)
- Indications Pulmonary tuberculosis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Janssen Research & Development
- 25 Jun 2019 Status changed from active, no longer recruiting to completed.
- 29 Jan 2019 Planned End Date changed from 31 Dec 2018 to 31 May 2019.
- 29 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 31 May 2019.